Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 385 to 389 of 389 entries
Sorted by: Best Match Show Resources per page
Molecular Main Group Metal Hydrides.

Chemical reviews

Roy MMD, Omaña AA, Wilson ASS, Hill MS, Aldridge S, Rivard E.
PMID: 34450005
Chem Rev. 2021 Oct 27;121(20):12784-12965. doi: 10.1021/acs.chemrev.1c00278. Epub 2021 Aug 27.

This review serves to document advances in the synthesis, versatile bonding, and reactivity of molecular main group metal hydrides within Groups 1, 2, and 12-16. Particular attention will be given to the emerging use of said hydrides in the...

Cite
Roy MMD, Omaña AA, Wilson ASS, et al. Molecular Main Group Metal Hydrides. Chem Rev. 2021;121(20):12784-12965doi: 10.1021/acs.chemrev.1c00278.
Roy, M. M. D., Omaña, A. A., Wilson, A. S. S., Hill, M. S., Aldridge, S., & Rivard, E. (2021). Molecular Main Group Metal Hydrides. Chemical reviews, 121(20), 12784-12965. https://doi.org/10.1021/acs.chemrev.1c00278
Roy, Matthew M D, et al. "Molecular Main Group Metal Hydrides." Chemical reviews vol. 121,20 (2021): 12784-12965. doi: https://doi.org/10.1021/acs.chemrev.1c00278
Roy MMD, Omaña AA, Wilson ASS, Hill MS, Aldridge S, Rivard E. Molecular Main Group Metal Hydrides. Chem Rev. 2021 Oct 27;121(20):12784-12965. doi: 10.1021/acs.chemrev.1c00278. Epub 2021 Aug 27. PMID: 34450005.
Copy Download .nbib Format: NLM
Comparison of Weight-Based Dosing versus Fixed Dosing of 23.4% Hypertonic Saline for Intracranial Pressure Reduction in Patients with Severe Traumatic Brain Injury.

Journal of emergencies, trauma, and shock

Busey K, Ferreira J, Aldridge P, Crandall M, Johnson D.
PMID: 33897140
J Emerg Trauma Shock. 2020 Oct-Dec;13(4):252-256. doi: 10.4103/JETS.JETS_66_19. Epub 2020 Dec 07.

CONTEXT: Hypertonic saline (HTS) is a pharmacologic therapy used in patients with severe traumatic brain injuries to decrease intracranial pressure (ICP) associated with cerebral edema.AIMS: The purpose of this study was to compare ICP reduction between fixed doses of...

Cite
Busey K, Ferreira J, Aldridge P, et al. Comparison of Weight-Based Dosing versus Fixed Dosing of 23.4% Hypertonic Saline for Intracranial Pressure Reduction in Patients with Severe Traumatic Brain Injury. J Emerg Trauma Shock. 2020;13(4):252-256doi: 10.4103/JETS.JETS_66_19.
Busey, K., Ferreira, J., Aldridge, P., Crandall, M., & Johnson, D. (2020). Comparison of Weight-Based Dosing versus Fixed Dosing of 23.4% Hypertonic Saline for Intracranial Pressure Reduction in Patients with Severe Traumatic Brain Injury. Journal of emergencies, trauma, and shock, 13(4), 252-256. https://doi.org/10.4103/JETS.JETS_66_19
Busey, Kirsten, et al. "Comparison of Weight-Based Dosing versus Fixed Dosing of 23.4% Hypertonic Saline for Intracranial Pressure Reduction in Patients with Severe Traumatic Brain Injury." Journal of emergencies, trauma, and shock vol. 13,4 (2020): 252-256. doi: https://doi.org/10.4103/JETS.JETS_66_19
Busey K, Ferreira J, Aldridge P, Crandall M, Johnson D. Comparison of Weight-Based Dosing versus Fixed Dosing of 23.4% Hypertonic Saline for Intracranial Pressure Reduction in Patients with Severe Traumatic Brain Injury. J Emerg Trauma Shock. 2020 Oct-Dec;13(4):252-256. doi: 10.4103/JETS.JETS_66_19. Epub 2020 Dec 07. PMID: 33897140; PMCID: PMC8047962.
Copy Download .nbib Format: NLM
The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN).

Journal of immunological methods

Rutten B, Young S, Aldridge S, Davies R, Fidock M, Newbold P, Singh D, Platt A, Hughes G.
PMID: 34762913
J Immunol Methods. 2022 Jan;500:113181. doi: 10.1016/j.jim.2021.113181. Epub 2021 Nov 09.

Eosinophil-derived neurotoxin (EDN) is a surrogate biomarker of eosinophil activation and has considerable potential as a precision medicine biomarker in diseases where eosinophils may play a causative role. Clinical data for EDN have been generated using different quantitative immunoassays,...

Cite
Rutten B, Young S, Aldridge S, et al. The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN). J Immunol Methods. 2021;500:113181doi: 10.1016/j.jim.2021.113181.
Rutten, B., Young, S., Aldridge, S., Davies, R., Fidock, M., Newbold, P., Singh, D., Platt, A., & Hughes, G. (2022). The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN). Journal of immunological methods, 500113181. https://doi.org/10.1016/j.jim.2021.113181
Rutten, Bert, et al. "The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN)." Journal of immunological methods vol. 500 (2022): 113181. doi: https://doi.org/10.1016/j.jim.2021.113181
Rutten B, Young S, Aldridge S, Davies R, Fidock M, Newbold P, Singh D, Platt A, Hughes G. The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN). J Immunol Methods. 2022 Jan;500:113181. doi: 10.1016/j.jim.2021.113181. Epub 2021 Nov 09. PMID: 34762913.
Copy Download .nbib Format: NLM
Rates of Adverse Events in Hospitalized Patients After Summer-Time Resident Changeover in the United States: Is There a July Effect?.

Journal of patient safety

Metersky ML, Eldridge N, Wang Y, Eckenrode S, Galusha D, Jaser L, Mathew J, Angus S, Nardino R.
PMID: 34387249
J Patient Saf. 2021 Aug 11; doi: 10.1097/PTS.0000000000000887. Epub 2021 Aug 11.

OBJECTIVES: This study aimed to determine whether patients in teaching hospitals are at higher risk of suffering from an adverse event during the summer trainee changeover period.METHODS: We performed a retrospective analysis of data from the Medicare Patient Safety...

Cite
Metersky ML, Eldridge N, Wang Y, et al. Rates of Adverse Events in Hospitalized Patients After Summer-Time Resident Changeover in the United States: Is There a July Effect?. J Patient Saf. 2021;doi: 10.1097/PTS.0000000000000887.
Metersky, M. L., Eldridge, N., Wang, Y., Eckenrode, S., Galusha, D., Jaser, L., Mathew, J., Angus, S., & Nardino, R. (2021). Rates of Adverse Events in Hospitalized Patients After Summer-Time Resident Changeover in the United States: Is There a July Effect?. Journal of patient safety, . https://doi.org/10.1097/PTS.0000000000000887
Metersky, Mark L, et al. "Rates of Adverse Events in Hospitalized Patients After Summer-Time Resident Changeover in the United States: Is There a July Effect?." Journal of patient safety vol. (2021). doi: https://doi.org/10.1097/PTS.0000000000000887
Metersky ML, Eldridge N, Wang Y, Eckenrode S, Galusha D, Jaser L, Mathew J, Angus S, Nardino R. Rates of Adverse Events in Hospitalized Patients After Summer-Time Resident Changeover in the United States: Is There a July Effect?. J Patient Saf. 2021 Aug 11; doi: 10.1097/PTS.0000000000000887. Epub 2021 Aug 11. PMID: 34387249.
Copy Download .nbib Format: NLM
Substrates of speech treatment-induced neuroplasticity in adults and children with motor speech disorders: A systematic scoping review of neuroimaging evidence.

International journal of speech-language pathology

Whelan BM, Theodoros D, Mcmahon KL, Copland D, Aldridge D, Campbell J.
PMID: 34030526
Int J Speech Lang Pathol. 2021 Dec;23(6):579-592. doi: 10.1080/17549507.2021.1908425. Epub 2021 May 24.

No abstract available.

Cite
Whelan BM, Theodoros D, Mcmahon KL, et al. Substrates of speech treatment-induced neuroplasticity in adults and children with motor speech disorders: A systematic scoping review of neuroimaging evidence. Int J Speech Lang Pathol. 2021;23(6):579-592doi: 10.1080/17549507.2021.1908425.
Whelan, B. M., Theodoros, D., Mcmahon, K. L., Copland, D., Aldridge, D., & Campbell, J. (2021). Substrates of speech treatment-induced neuroplasticity in adults and children with motor speech disorders: A systematic scoping review of neuroimaging evidence. International journal of speech-language pathology, 23(6), 579-592. https://doi.org/10.1080/17549507.2021.1908425
Whelan, Brooke-Mai, et al. "Substrates of speech treatment-induced neuroplasticity in adults and children with motor speech disorders: A systematic scoping review of neuroimaging evidence." International journal of speech-language pathology vol. 23,6 (2021): 579-592. doi: https://doi.org/10.1080/17549507.2021.1908425
Whelan BM, Theodoros D, Mcmahon KL, Copland D, Aldridge D, Campbell J. Substrates of speech treatment-induced neuroplasticity in adults and children with motor speech disorders: A systematic scoping review of neuroimaging evidence. Int J Speech Lang Pathol. 2021 Dec;23(6):579-592. doi: 10.1080/17549507.2021.1908425. Epub 2021 May 24. PMID: 34030526.
Copy Download .nbib Format: NLM
Showing 385 to 389 of 389 entries